Insight Molecular Diagnostics (IMDX) Debt Ratio (2015 - 2026)

Insight Molecular Diagnostics (IMDX) has 12 years of Debt Ratio data on file, last reported at 0.0 in Q1 2026.

• Quarterly Debt Ratio fell 45.17% year-over-year to 0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0 (down 45.17% YoY) and the FY2025 annual result came in at 0.02, up 155.68% from the prior year.
• Debt Ratio retreated to 0.0 in Q1 2026 per IMDX's latest filing, from 0.02 in the prior quarter.
• The five-year high for Debt Ratio was 0.03 in Q4 2023, with the low at 0.0 in Q3 2022.
• Average Debt Ratio over 5 years is 0.01, with a median of 0.0 recorded in 2022.
• Year-over-year, Debt Ratio plunged 94.86% in 2022 and jumped 2737.24% in 2023.
• Insight Molecular Diagnostics' Debt Ratio stood at 0.0 in 2022, then jumped by 2737.24% to 0.03 in 2023, then sank by 78.97% to 0.01 in 2024, then soared by 155.68% to 0.02 in 2025, then sank by 76.33% to 0.0 in 2026.
• Business Quant data shows IMDX's Debt Ratio at 0.0 in Q1 2026, 0.02 in Q4 2025, and 0.02 in Q3 2025.